Wang et al. credentialed BCL9 as a candidate driver gene as it plays a significant role in HCC growth and survival and may serve as a potential therapeutic target for the disease treatment, as it found a significant correlation between BCL9 somatic copy number and gene expression in primary HCCs [59]. This evidence concerns the gene BCL9 and hepatocellular carcinoma.